These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28948379)

  • 41. Periodontitis and Systemic Lupus Erythematosus: A systematic review and meta-analysis.
    Hussain SB; Leira Y; Zehra SA; Botelho J; Machado V; Ciurtin C; D'Aiuto F; Orlandi M
    J Periodontal Res; 2022 Jan; 57(1):1-10. PubMed ID: 34608627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence and prevalence of tuberculosis in systemic lupus erythematosus patients: A systematic review and meta-analysis.
    Wu Q; Liu Y; Wang W; Zhang Y; Liu K; Chen SH; Chen B
    Front Immunol; 2022; 13():938406. PubMed ID: 35935948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII.
    Cheng C; Huang C; Chen Z; Zhan F; Duan X; Wang Y; Zhao C; Wu Z; Xu J; Li H; Yang M; Wu R; Zhao J; Zhang S; Wang Q; Leng X; Tian X; Li M; Zeng X
    Arthritis Res Ther; 2023 May; 25(1):78. PubMed ID: 37173771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.
    Chen Z; Zhong H; Dong G
    Am J Med Sci; 2019 Jun; 357(6):461-467. PubMed ID: 30987767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transitional changes in the incidence of osteonecrosis in systemic lupus erythematosus patients: focus on immunosuppressant agents and glucocorticoids.
    Nawata K; Nakamura J; Ikeda K; Furuta S; Nakajima H; Ohtori S; Hagiwara S; Wako Y; Miura M; Kawarai Y; Sugano M; Yoshino K; Orita S; Inage K; Akazawa T
    Rheumatology (Oxford); 2018 May; 57(5):844-849. PubMed ID: 29462407
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study.
    Nakamura J; Saisu T; Yamashita K; Suzuki C; Kamegaya M; Takahashi K
    Arthritis Rheum; 2010 Feb; 62(2):609-15. PubMed ID: 20112393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Osteonecroses in systemic lupus erythematosus and antiphospholipid syndrome].
    Reshetniak TM; Lisitsyna TA; Nasonov EL
    Klin Med (Mosk); 2004; 82(6):46-51. PubMed ID: 15344691
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Meta-analysis of effectiveness and safety of glucocorticoid combined with hydroxychloroquine in the treatment of systemic lupus erythematosus rash.
    Liang S; Wei Z; Fang H; Guan T
    Int J Rheum Dis; 2023 Sep; 26(9):1686-1696. PubMed ID: 37496262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
    Keeling SO; Alabdurubalnabi Z; Avina-Zubieta A; Barr S; Bergeron L; Bernatsky S; Bourre-Tessier J; Clarke A; Baril-Dionne A; Dutz J; Ensworth S; Fifi-Mah A; Fortin PR; Gladman DD; Haaland D; Hanly JG; Hiraki LT; Hussein S; Legault K; Levy D; Lim L; Matsos M; McDonald EG; Medina-Rosas J; Pardo Pardi J; Peschken C; Pineau C; Pope J; Rader T; Reynolds J; Silverman E; Tselios K; Suitner M; Urowitz M; Touma Z; Vinet E; Santesso N
    J Rheumatol; 2018 Oct; 45(10):1426-1439. PubMed ID: 30173152
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis.
    Seo MS; Yeo J; Hwang IC; Shim JY
    Clin Rheumatol; 2019 Nov; 38(11):3109-3116. PubMed ID: 31270697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of systemic lupus erythematosus on sexual function in women: an updated meta-analysis based on cross-sectional studies.
    Liu M; Dou J; Wang Q
    Adv Rheumatol; 2022 Jul; 62(1):24. PubMed ID: 35787296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Central nervous system infections in patients with systemic lupus erythematosus: a systematic review and meta-analysis.
    Molooghi K; Sheybani F; Naderi H; Mirfeizi Z; Morovatdar N; Baradaran A
    Lupus Sci Med; 2022 Jan; 9(1):. PubMed ID: 34980679
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Belimumab for systemic lupus erythematosus.
    Singh JA; Shah NP; Mudano AS
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD010668. PubMed ID: 33631841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis.
    Sun C; Qin W; Zhang YH; Wu Y; Li Q; Liu M; He CD
    Int J Rheum Dis; 2017 Aug; 20(8):917-928. PubMed ID: 28851080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum Adiponectin Levels in Patients With Systemic Lupus Erythematosus: A Meta-analysis.
    Dini AA; Wang P; Ye DQ
    J Clin Rheumatol; 2017 Oct; 23(7):361-367. PubMed ID: 28937471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of association between mean platelet volume and disease activity in systemic lupus erythematosus patients: a systematic review and meta-analysis.
    Zhao CN; Mao YM; Wang P; Guan SY; Sam NB; Li XM; Wang DG; Pan HF
    Rheumatol Int; 2018 Sep; 38(9):1635-1641. PubMed ID: 29845430
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic lupus erythematous increased lung cancer risk: Evidence from a meta-analysis.
    Wu Y; Hou Q
    J Cancer Res Ther; 2016; 12(2):721-4. PubMed ID: 27461640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of incidence and clinical characteristics of osteonecrosis of femoral head in patients with systemic lupus erythematosus treated with glucocorticoid: A descriptive study based on a prospective cohort].
    Xu Y; Chen S; Cai Q; Zhang C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 May; 37(5):605-614. PubMed ID: 37190840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: A systematic review and meta-analysis.
    Dai L; Chan KK; Mao JC; Tian Y; Gu JH; Zhou J; Zhong LLD
    J Integr Med; 2020 Nov; 18(6):478-491. PubMed ID: 32907784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic lupus erythematosus and risk of preterm birth: a systematic review and meta-analysis of observational studies.
    Wei S; Lai K; Yang Z; Zeng K
    Lupus; 2017 May; 26(6):563-571. PubMed ID: 28121241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.